ba0001pp422 | Osteoporosis: treatment | ECTS2013
Maria Buyko
, Victoria Atrushkevich
Introduction: Bisphosphonates gain increasingly greater significance in treatment oncologic diseases with bone metastasis. However, a lot of articles have lately been published in dental and oncological journals on jaw osteonecrosis (ONJ) associated with long-term ingestion of bisphosphonates. Besides extension of clinical recommendations for zolendronate use, most commonly referred to in connection with ONJ, for treatment of Pagets diseaseand other disturbances of bone ...